copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Ezetimibe | Drugs | BNF | NICE View ezetimibe information, including dose, uses, side-effects, pregnancy, breast feeding and drug action
Ezetimibe | Interactions | BNF | NICE See the list of drugs that interact with Ezetimibe Includes information on severity of interaction and the level of evidence for it
Dyslipidaemias | Treatment summaries | BNF | NICE Patients with primary heterozygous familial hypercholesterolaemia who have contra-indications to, or are intolerant of statins, can be considered for treatment with ezetimibe as monotherapy A combination of a statin and ezetimibe is recommended if the maximum tolerated dose of a statin alone fails to provide adequate control of LDL-cholesterol
Bempedoic acid with ezetimibe | Drugs | BNF | NICE Bempedoic acid with ezetimibe (Nustendi®) for use in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia (October 2021) Funding decision: Recommended with restrictions
Simvastatin with ezetimibe | Drugs | BNF | NICE Ezetimibe; Indications and dose For simvastatin with ezetimibe Homozygous familial hypercholesterolaemia, primary hypercholesterolaemia, and mixed hyperlipidaemia in patients over 10 years stabilised on the individual components in the same proportions, or for patients not adequately controlled by statin alone for simvastatin with ezetimibe By
Cardiovascular disease risk assessment and prevention NICE (2023) recommends that additional lipid-lowering treatments, such as alirocumab, bempedoic acid, evolocumab, ezetimibe, and inclisiran can be considered for secondary prevention of CVD when the maximum tolerated dose of statin therapy fails to adequately control lipid concentrations Ezetimibe in combination with the maximum tolerated dose
Rosuvastatin | Drugs | BNF | NICE Simvastatin with ezetimibe The content on the NICE BNF site (BNF) is the copyright of BMJ Publishing Group Ltd and the Royal Pharmaceutical Society of Great Britain By using BNF, you agree to the licence set out in the BNF Publications End User Licence Agreement
Simvastatin | Drugs | BNF | NICE Manufacturer advises usual max 20 mg daily with concurrent use of bempedoic acid or bempedoic acid with ezetimibe; max dose 40 mg daily in patients with severe hypercholesterolaemia and at high risk of cardiovascular complications
Bempedoic acid | Drugs | BNF | NICE Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia (April 2021)